// Press Release

April 29th, 2021

Alberta sites join network of certified centres to deliver CAR-T therapy, Kymriah® (tisagenlecleucel)

Alberta sites join network of certified centres to deliver CAR-T therapy, Kymriah® (tisagenlecleucel) Expansion of treatment centre network includes two specialized centres in Alberta certified to deliver Kymriah to Canadian patients with relapsed/refractory (r/r) pediatric and young adult B-cell ALL and adult r/r DLBCL Alberta joins Quebec and Ontario to reimburse Kymriah therapy for these life-threatening … Continue reading Alberta sites join network of certified centres to deliver CAR-T therapy, Kymriah® (tisagenlecleucel)

April 29th, 2021

Trillium Therapeutics Provides Data Update, Announces Phase 1b/2 Program Priorities Across Hematologic Malignancies and Solid Tumors, and Reports Governance Changes

Trillium Therapeutics Provides Data Update, Announces Phase 1b/2 Program Priorities Across Hematologic Malignancies and Solid Tumors, and Reports Governance Changes TTI-622 monotherapy shows 33% objective response rate (ORR) in relapsed/refractory (R/R) lymphomas at 0.8-18 mg/kg doses, including 3 new responses (1 Complete Response (CR) + 2 Partial Responses (PRs)) since last data disclosure; TTI-621 monotherapy … Continue reading Trillium Therapeutics Provides Data Update, Announces Phase 1b/2 Program Priorities Across Hematologic Malignancies and Solid Tumors, and Reports Governance Changes

April 29th, 2021

Trillium Therapeutics Announces Dosing of First Patient in Phase 1b Study of TTI-622 in Combination With Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma

Trillium Therapeutics Announces Dosing of First Patient in Phase 1b Study of TTI-622 in Combination With Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma CAMBRIDGE, Mass., April 28, 2021 (GLOBE NEWSWIRE) — Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced that it has dosed the first multiple … Continue reading Trillium Therapeutics Announces Dosing of First Patient in Phase 1b Study of TTI-622 in Combination With Carfilzomib and Dexamethasone in Relapsed/Refractory Multiple Myeloma

April 29th, 2021

Syqe Medical® Receives Health Canada Approval for the First-Ever Medical Cannabis Delivery Device with Predictable, Consistent Dosing

Syqe Medical® Receives Health Canada Approval for the First-Ever Medical Cannabis Delivery Device with Predictable, Consistent Dosing The novel Syqe® Inhaler with its precision dosing helps relieve symptoms with lower risk of adverse reactions TORONTO, April 28, 2021 /CNW/ – Syqe Medical®, a leading global pharma-tech company, announces today that Health Canada has approved the Syqe® Inhaler, the … Continue reading Syqe Medical® Receives Health Canada Approval for the First-Ever Medical Cannabis Delivery Device with Predictable, Consistent Dosing

April 29th, 2021

Marigold PR Announces Agenda and Expert-Driven Lineup for Second Annual Womxn, Wellness, and Cannabis Conference

Marigold PR Announces Agenda and Expert-Driven Lineup for Second Annual Womxn, Wellness, and Cannabis Conference Toronto, ON, April 28, 2021 (GLOBE NEWSWIRE) — Award-winning cannabis marketing and PR firm, Marigold PR, today announced the agenda for its second annual Womxn, Wellness and Cannabis Conference (WWC Conference) on May 26-27, 2021.  Hosted in celebration of the feminine cannabis and psychedelic experience, … Continue reading Marigold PR Announces Agenda and Expert-Driven Lineup for Second Annual Womxn, Wellness, and Cannabis Conference

April 29th, 2021

You Can TRUST Him When Your Life is Spinning Out of Control

You Can TRUST Him When Your Life is Spinning Out of Control Houston, TX, April 27, 2021 — The disruption and difficulties of 2020 also uprooted our time with the Lord when churches closed their doors and our daily routines changed dramatically. Many people lost their jobs or lost their loved ones, despite praying diligently for different … Continue reading You Can TRUST Him When Your Life is Spinning Out of Control

April 28th, 2021

Calgary Based Travel Clinic expanding Private Covid Testing to all major cities in Canada

Calgary Based Travel Clinic expanding Private Covid Testing to all major cities in Canada CALGARY, AB, April 27, 2021 /CNW/ – Head quartered in Calgary, Canadian Travel Clinics is one of the leading names in the travel healthcare industry of Canada. The company’s successful expansion in providing Covid-19 RT-PCR testing is 100 percent patient focused and currently operates … Continue reading Calgary Based Travel Clinic expanding Private Covid Testing to all major cities in Canada

April 28th, 2021

Agilex Biolabs and B2S Life Sciences on Immunoassay Bioanalysis for Clinical Trials

Agilex Biolabs and B2S Life Sciences on Immunoassay Bioanalysis for Clinical Trials ADELAIDE, AUS, Apr 29, 2021 – (ACN Newswire) – Agilex Biolabs, Australia’s largest and most technologically advanced specialist bioanalytical laboratory for clinical trials, and B2S Life Sciences, a biotherapeutic enablement company advancing improved analytical methods and outcomes for developers of biotherapeutic drugs and … Continue reading Agilex Biolabs and B2S Life Sciences on Immunoassay Bioanalysis for Clinical Trials

April 28th, 2021

EMD Serono Announces New Data Strengthening Evidence for Use of MAVENCLAD® During the COVID-19 Pandemic

EMD Serono Announces New Data Strengthening Evidence for Use of MAVENCLAD® During the COVID-19 Pandemic New analysis indicates a specific immune repopulation pattern in people treated with PrMAVENCLAD®, which may allow the ability to fight infections and develop protective antibodies from vaccine 1 Independent study from Israel showed MAVENCLAD-treated patients receiving COVID-19 vaccine were able to mount … Continue reading EMD Serono Announces New Data Strengthening Evidence for Use of MAVENCLAD® During the COVID-19 Pandemic

April 28th, 2021

TELUS Health launches next evolution of its national employer-focused Virtual Care service

TELUS Health launches next evolution of its national employer-focused Virtual Care service Enhanced service focused on personal human connections; brings together best-in-class features of its Akira by TELUS Health and EQ Care virtual care services VANCOUVER, British Columbia, April 28, 2021 (GLOBE NEWSWIRE) — TELUS Health, Canada’s largest health IT company and the leading provider … Continue reading TELUS Health launches next evolution of its national employer-focused Virtual Care service

TRAIN IT RIGHT NEWSLETTER

Sign Up and get a free 7 day Train it Right HIIT Program!

Top
WP Twitter Auto Publish Powered By : XYZScripts.com